These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 18156935)
1. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study. Bergkvist L; de Boniface J; Jönsson PE; Ingvar C; Liljegren G; Frisell J; Ann Surg; 2008 Jan; 247(1):150-6. PubMed ID: 18156935 [TBL] [Abstract][Full Text] [Related]
2. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study. Bulte CS; van der Heiden-van der Loo M; Hennipman A Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809 [TBL] [Abstract][Full Text] [Related]
3. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064 [TBL] [Abstract][Full Text] [Related]
4. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years. Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787 [TBL] [Abstract][Full Text] [Related]
5. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Roumen RM; Kuijt GP; Liem IH; van Beek MW Br J Surg; 2001 Dec; 88(12):1639-43. PubMed ID: 11736979 [TBL] [Abstract][Full Text] [Related]
6. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node. Snoj M; Bracko M; Zagar I Croat Med J; 2005 Jun; 46(3):377-81. PubMed ID: 15861515 [TBL] [Abstract][Full Text] [Related]
7. [Negative sentinel node in breast cancer patients a good indicator for continued absence of axillary metastases]. Meijer S; Torrenga H; van der Sijp JR Ned Tijdschr Geneeskd; 2002 May; 146(20):942-6. PubMed ID: 12051063 [TBL] [Abstract][Full Text] [Related]
8. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years. Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841 [TBL] [Abstract][Full Text] [Related]
9. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295 [TBL] [Abstract][Full Text] [Related]
10. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration. van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534 [TBL] [Abstract][Full Text] [Related]
11. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Veronesi U; Galimberti V; Mariani L; Gatti G; Paganelli G; Viale G; Zurrida S; Veronesi P; Intra M; Gennari R; Rita Vento A; Luini A; Tullii M; Bassani G; Rotmensz N Eur J Cancer; 2005 Jan; 41(2):231-7. PubMed ID: 15661547 [TBL] [Abstract][Full Text] [Related]
12. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Zavagno G; De Salvo GL; Scalco G; Bozza F; Barutta L; Del Bianco P; Renier M; Racano C; Carraro P; Nitti D; Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523 [TBL] [Abstract][Full Text] [Related]
13. Medium-term follow-up data after sentinel node biopsy alone for breast cancer. Haid A; Knauer M; Köberle-Wührer R; Ammann K; Koller L; Eiter H; Lang A; Wenzl E Eur J Surg Oncol; 2006 Dec; 32(10):1180-5. PubMed ID: 16750344 [TBL] [Abstract][Full Text] [Related]
14. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151 [TBL] [Abstract][Full Text] [Related]
15. Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer. Andersson Y; de Boniface J; Jönsson PE; Ingvar C; Liljegren G; Bergkvist L; Frisell J; ; Br J Surg; 2012 Feb; 99(2):226-31. PubMed ID: 22180063 [TBL] [Abstract][Full Text] [Related]
16. Sentinel node biopsy in elderly breast cancer patients. Gennari R; Rotmensz N; Perego E; dos Santos G; Veronesi U Surg Oncol; 2004 Dec; 13(4):193-6. PubMed ID: 15615656 [TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients. Langer I; Kocher T; Guller U; Torhorst J; Oertli D; Harder F; Zuber M Breast Cancer Res Treat; 2005 Mar; 90(1):85-91. PubMed ID: 15770531 [TBL] [Abstract][Full Text] [Related]
19. Axillary recurrence after negative sentinel lymph node biopsy: frequency and factors influencing recurrence on the long term. Sanli I; Lemaire BM; Muller AJ; van Kleffens HJ; Van Poll-Franse LV; van Dijk M Breast J; 2009; 15(3):236-41. PubMed ID: 19645777 [TBL] [Abstract][Full Text] [Related]
20. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. Zavagno G; Carcoforo P; Franchini Z; Renier M; Barutta L; De Salvo GL; Maravegias K; Capitanio G; Nitti D; Lise M Eur J Surg Oncol; 2005 Sep; 31(7):715-20. PubMed ID: 16005176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]